[1. N. A. Alqallaf, H. A. G. Saleh, A. M. Abdu, S. H. Almuntaser, S. A. Bin Rakhis, A. A. Almughamis, A. A. Ghanim, A. S. Alkhathami, N. A. Aldossari and G. M. Ahmad, Colon cancer screening and prevention, Indo. Am. J. Pharm. Sci.5 (2018) 13071–13078; https://doi.org/10.5281/zenodo.1495157]Search in Google Scholar
[2. R. L. Siegel, K. D. Miller, S. A. Fedewa, D. J. Ahnen, R. G. S. Meester, A. Barzi and A. Jemal, Colorectal cancer statistics, CA: Cancer J. Clin.67 (2017) 177–193; https://doi.org/10.3322/caac.2139510.3322/caac.2139528248415]Search in Google Scholar
[3. H. S. Wong and W. C. Chang, Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers, Oncotarget6 (2015) 42169–42182; https://doi.org/10.18632/oncotarget.588810.18632/oncotarget.5888474721726543234]Search in Google Scholar
[4. B. K. Edwards, E. Ward, B. A. Kohler, C. Eheman, A. G. Zauber, R. N. Anderson, A. Jemal, M. J. Schymura, I. Lansdorp-Vogelaar, L. C. Seeff, M. van Ballegooijen, S. L. Goede and L. A. G. Ries, Annual report to the nation on the status of cancer, 1975-2006, Featuring colorectal cancer trends and impact of interventions (Risk factors, screening, and treatment) to reduce future rates, Cancer116 (2010) 544–573; https://doi.org/10.1002/cncr.2476010.1002/cncr.24760361972619998273]Search in Google Scholar
[5. M. Wang, Y. R. Li and X. D. Hu, Chebulinic acid derived from triphala is a promising antitumour agent in human colorectal carcinoma cell lines, BMC Complement. Altern. Med.18 (2018) 342; https://doi.org/10.1186/s12906-018-2412-510.1186/s12906-018-2412-5630717430587184]Search in Google Scholar
[6. H. M. Li, S. Krstin and M. Wink, Modulation of multidrug resistant in cancer cells by EGCG, tannic acid and curcumin, Phytomedicine50 (2018) 213–222; https://doi.org/10.1016/j.phymed.2018.09.16910.1016/j.phymed.2018.09.16930466981]Search in Google Scholar
[7. Y. M. Zheng, J. Z. Shen, Y. Wang, A. X. Lu and W. S. Ho, Anti-oxidant and anti-cancer activities of Angelica dahurica extract via induction of apoptosis in colon cancer cells, Phytomedicine23 (2016) 1267–1274; https://doi.org/10.1016/j.phymed.2015.11.00810.1016/j.phymed.2015.11.00826776960]Search in Google Scholar
[8. S. Dasari and P. B. Tchounwou, Cisplatin in cancer therapy: molecular mechanisms of action, Eur. J. Pharmacol.740 (2014) 364–378; https://doi.org/10.1016/j.ejphar.2014.07.02510.1016/j.ejphar.2014.07.025414668425058905]Search in Google Scholar
[9. P. Apostolou, M. Toloudi, M. Chatziioannou, E. Ioannou, D. R. Knocke, J. Nester, D. Komiotis and I. Papasotiriou, Anvirzel in combination with cisplatin in breast, colon, lung, prostate, melanoma and pancreatic cancer cell lines, BMC Pharmacol. Toxicol.14 (2013) 18; https://doi.org/10.1186/2050-6511-14-1810.1186/2050-6511-14-18363717223521834]Search in Google Scholar
[10. G. Maisetta, G. Batoni, P. Caboni, S. Esin, A. C. Rinaldi and P. Zucca, Tannin profile, antioxidant properties, and antimicrobial activity of extracts from two Mediterranean species of parasitic plant Cytinus, BMC Complement. Altern. Med.19 (2019) 82; https://doi.org/10.1186/s12906-019-2487-710.1186/s12906-019-2487-7645122530952208]Search in Google Scholar
[11. J. Dai and R. J. Mumper, Plant phenolics: extraction, analysis and their antioxidant and anticancer properties, Molecules15 (2010) 7313–7352; https://doi.org/10.3390/molecules1510731310.3390/molecules15107313625914620966876]Search in Google Scholar
[12. M. P. Borisova, A. A. Kataev and V. S. Sivozhelezov, Action of tannin on cellular membranes: Novel insights from concerted studies on lipid bilayers and native cells, BBA – Biomembrane1861 (2019) 1103–1111; https://doi.org/10.1016/j.bbamem.2019.03.01710.1016/j.bbamem.2019.03.017]Search in Google Scholar
[13. S. Karakurt and O. Adali, Effect of tannic acid on glutathione S-transferase and NAD(P)H: Quinone oxidoreductase 1 enzymes in rabbit liver and kidney, Fresen. Environ. Bull.20 (2011) 1804–1811.]Search in Google Scholar
[14. S. Quideau, D. Deffieux, C. Douat-Casassus and L. Pouysegu, Plant polyphenols: Chemical properties, biological activities, and synthesis, Angew. Chem. Int. Edit.50 (2011) 586–621; https://doi.org/10.1002/anie.20100004410.1002/anie.201000044]Search in Google Scholar
[15. J. Das, R. Ramani and M. O. Suraju, Polyphenol compounds and PKC signaling, Biochim. Biophys. Acta1860 (2016) 2107–2121; https://doi.org/10.1016/j.bbagen.2016.06.02210.1016/j.bbagen.2016.06.022]Search in Google Scholar
[16. N. Sahiner, S. Sagbas, N. Aktas and C. Silan, Inherently antioxidant and antimicrobial tannic acid release from poly(tannic acid) nanoparticles with controllable degradability, Colloid Surface B142 (2016) 334–343; https://doi.org/10.1016/j.colsurfb.2016.03.00610.1016/j.colsurfb.2016.03.006]Search in Google Scholar
[17. J. Zhang, D. Chen, D. M. Han, Y. H. Cheng, C. Dai, X. J. Wu, F. Y. Che and X. Y. Heng, Tannic acid mediated induction of apoptosis in human glioma Hs 683 cells, Oncol. Lett.15 (2018) 6845–6850; https://doi.org/10.3892/ol.2018.819710.3892/ol.2018.8197]Search in Google Scholar
[18. Y. Ren, X. Li, B. Han, N. Zhao, M. Mu, C. Wang, Y. Du, Y. Wang, A. Tong, Y. Liu, L. Zhou, C. You and G. Guo, Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel, Eur. J. Pharm. Sci.128 (2019) 279–289; https://doi.org/10.1016/j.ejps.2018.12.00710.1016/j.ejps.2018.12.007]Search in Google Scholar
[19. X. Zhang, H. Zhang, N. Zhou, J. Xu, M. Si, Z. Jia, X. Du and H. Zhang, Tannic acid modulates excitability of sensory neurons and nociceptive behavior and the Ionic mechanism, Eur. J. Pharmacol.764 (2015) 633–642; https://doi.org/10.1016/j.ejphar.2015.06.04810.1016/j.ejphar.2015.06.048]Search in Google Scholar
[20 G. Goel, A. K. Puniya and K. Singh, Tannic acid resistance in ruminal streptococcal isolates, J. Basic Microbiol.45 (2005) 243–245; https://doi.org/10.1002/jobm.20041051710.1002/jobm.200410517]Search in Google Scholar
[21. G. K. Lopes, H. M. Schulman and M. Hermes-Lima, Polyphenol tannic acid inhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions, Biochim. Biophys. Acta1472 (1999) 142–152; https://doi.org/10.1016/s0304-4165(99)00117-810.1016/S0304-4165(99)00117-8]Search in Google Scholar
[22. L. Ernster, L. Danielson and M. Ljunggren, Dt diaphorase I. Purification from the soluble fraction of rat-liver cytoplasm, and properties, Biochim. Biophys. Acta58 (1962) 171–188; https://doi.org/10.1016/0006-3002(62)90997-610.1016/0006-3002(62)90997-6]Search in Google Scholar
[23. Z. Anusevicius, J. Sarlauskas and N. Cenas, Two-electron reduction of quinones by rat liver NAD(P) H:quinone oxidoreductase: quantitative structure-activity relationships, Arch. Biochem. Biophys.404 (2002) 254–262; https://doi.org/10.1016/S0003-9861(02)00273-410.1016/S0003-9861(02)00273-4]Search in Google Scholar
[24. N. Hamajima, K. Matsuo, H. Iwata, M. Shinoda, Y. Yamamura, T. Kato, S. Hatooka, T. Mitsudomi, M. Suyama, Y. Kagami, M. Ogura, M. Ando, Y. Sugimura and K. Tajima, NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese, Int. J. Clin. Oncol.7 (2002) 103–108; https://doi.org/10.1007/s10147020001310.1007/s10147020001312018106]Search in Google Scholar
[25. H. J. Menzel, J. Sarmanova, P. Soucek, R. Berberich, K. Grunewald, M. Haun and H. G. Kraft, Association of NQO1 polymorphism with spontaneous breast cancer in two independent populations, Br. J. Cancer90 (2004) 1989–1994; https://doi.org/10.1038/sj.bjc.660177910.1038/sj.bjc.6601779241028215138483]Search in Google Scholar
[26. A. T. Dinkova-Kostova and P. Talalay, NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector, Arch. Biochem. Biophys.501 (2010) 116–123; https://doi.org/10.1016/j.abb.2010.03.01910.1016/j.abb.2010.03.019293003820361926]Search in Google Scholar
[27. G. Asher, P. Tsvetkov, C. Kahana and Y. Shaul, A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73, Genes Dev.19 (2005) 316–321; https://doi.org/10.1101/gad.31990510.1101/gad.31990554650915687255]Search in Google Scholar
[28. G. Asher, Z. Bercovich, P. Tsvetkov, Y. Shaul and C. Kahana, 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1, Mol. Cell.17 (2005) 645–655; https://doi.org/10.1016/j.molcel.2005.01.02010.1016/j.molcel.2005.01.02015749015]Search in Google Scholar
[29. K. Mikami, M. Naito, T. Ishiguro, H. Yano, A. Tomida, T. Yamada, N. Tanaka, T. Shirakusa and T. Tsuruo, Immunological quantitation of DT-diaphorase in carcinoma cell lines and clinical colon cancers: advanced tumors express greater levels of DT-diaphorase, Jpn. J. Cancer Res.89 (1998) 910–915; https://doi.org/10.1111/j.1349-7006.1998.tb00648.x10.1111/j.1349-7006.1998.tb00648.x59219499818026]Search in Google Scholar
[30. O. J. Achadu and N. Revaprasadu, Tannic acid-derivatized graphitic carbon nitride quantum dots as an “on-off-on” fluorescent nanoprobe for ascorbic acid via copper(II) mediation, Mikrochim. Acta186 (2019) 87; https://doi.org/10.1007/s00604-018-3203-x10.1007/s00604-018-3203-x30631929]Search in Google Scholar
[31. S. Karakurt and O. Adali, Tannic acid inhibits proliferation, migration, invasion of prostate cancer and modulates drug metabolizing and antioxidant enzymes, Anticancer Agents Med. Chem. 16 (2016) 781–789; https://doi.org/10.2174/187152061666615111111580910.2174/187152061666615111111580926555610]Search in Google Scholar
[32. S. Karakurt, G. Abuşoğlu and Z. C. Arituluk, Comparison of anticarcinogenic properties of Viburnum opulus and its active compound p-coumaric acid on human colorectal carcinoma, Turk. J. Biol. 44 (2020) 252–263; https://doi.org/10.3906/biy-2002-3010.3906/biy-2002-30758515733110363]Search in Google Scholar
[33. R. E. Brown, K. L. Jarvis and K. J. Hyland, Protein measurement using bicinchoninic acid – elimination of interfering substances, Anal. Biochem. 180 (1989) 136–139; https://doi.org/10.1016/0003-2697(89)90101-210.1016/0003-2697(89)90101-2]Search in Google Scholar
[34. P. K. Smith, R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fuji-moto, N. M. Goeke, B. J. Olson and D. C. Klenk, Measurement of protein using bicinchoninic acid, Anal. Biochem. 150 (1985) 76–85; https://doi.org/10.1016/0003-2697(85)90442-710.1016/0003-2697(85)90442-7]Search in Google Scholar
[35. K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods25 (2001) 402–408; https://doi.org/10.1006/meth.2001.126210.1006/meth.2001.126211846609]Search in Google Scholar
[36. H. P. S. Makkar and K. Becker, Effect of pH, temperature, and time on inactivation of tannins and possible implications in detannification studies, J. Agr. Food Chem. 44 (1996) 1291–1295; https://doi.org/10.1021/jf950628710.1021/jf9506287]Search in Google Scholar
[37. L. C. Katwa, M. Ramakrishna and M. R. R. Rao, Spectrophotometric assay of immobilized tannase, J. Biosci. 3 (1981) 135–142; https://doi.org/10.1007/BF0270265610.1007/BF02702656]Search in Google Scholar
[38. S. R. Vedula, A. Ravasio, C. T. Lim and B. Ladoux, Collective cell migration: a mechanistic perspective, Physiology (Bethesda)28 (2013) 370–379; https://doi.org/10.1152/physiol.00033.201310.1152/physiol.00033.201324186932]Search in Google Scholar
[39. O. Ilina and P. Friedl, Mechanisms of collective cell migration at a glance, J. Cell Sci. 122 (2009) 3203–3208; https://doi.org/10.1242/jcs.03652510.1242/jcs.03652519726629]Search in Google Scholar
[40. P. Vitorino and T. Meyer, Modular control of endothelial sheet migration, Genes Dev. 22 (2008) 3268–3281; https://doi.org/10.1101/gad.172580810.1101/gad.1725808260076719056882]Search in Google Scholar
[41. D. A. Chapnick and X. Liu, Leader cell positioning drives wound-directed collective migration in TGFbeta-stimulated epithelial sheets, Mol. Biol. Cell25 (2014) 1586–1593; https://doi.org/10.1091/mbc.E14-01-069710.1091/mbc.e14-01-0697]Search in Google Scholar
[42. X. Liu and X. Wu, Utilizing matrigel transwell invasion assay to detect and enumerate circulating tumor cells, Methods Mol. Biol. 1634 (2017) 277–282; https://doi.org/10.1007/978-1-4939-7144-2_2310.1007/978-1-4939-7144-2_2328819859]Search in Google Scholar
[43. K. Soejima, N. Mimura, M. Hirashima, H. Maeda, T. Hamamoto, T. Nakagaki and C. Nozaki, A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease?, J. Biochem. 130 (2001) 475–480; https://doi.org/10.1093/oxford-journals.jbchem.a003009]Search in Google Scholar
[44. S. Horibata, T. V. Vo, V. Subramanian, P. R. Thompson and S. A. Coonrod, Utilization of the soft agar colony formation assay to identify inhibitors of tumorigenicity in breast cancer cells, J. Vis. Exp. 99 (2015) e52727; https://doi.org/10.3791/5272710.3791/52727]Search in Google Scholar
[45. S. Borowicz, M. Van Scoyk, S. Avasarala, M. K. Karuppusamy Rathinam, J. Tauler, R. K. Bikkavilli and R. A. Winn, The soft agar colony formation assay, J. Vis. Exp. 92 (2014) e51998; https://doi.org/10.3791/5199810.3791/51998]Search in Google Scholar
[46. S. Elmore, Apoptosis: a review of programmed cell death, Toxicol Pathol. 35 (2007) 495–516; https://doi.org/10.1080/0192623070132033710.1080/01926230701320337]Search in Google Scholar
[47. M. M. Metzstein, G. M. Stanfield and H. R. Horvitz, Genetics of programmed cell death in C. elegans: past, present and future, Trends Genet. 14 (1998) 410–416; https://doi.org/10.1016/s0168-9525(98)01573-x10.1016/S0168-9525(98)01573-X]Search in Google Scholar
[48. T. Miyashita, S. Krajewski, M. Krajewska, H. G. Wang, H. K. Lin, D. A. Liebermann, B. Hoffman and J. C. Reed, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo, Oncogene9 (1994) 1799–1805; https://doi.org/10.1016/0092-8674(95)90412-310.1016/0092-8674(95)90412-3]Search in Google Scholar
[49. A. A. Roman-Rosales, E. Garcia-Villa, L. A. Herrera, P. Gariglio and J. Diaz-Chavez, Mutant p53 gain of function induces HER2 over-expression in cancer cells, BMC Cancer18 (2018) 709; https://doi.org/10.1186/s12885-018-4613-110.1186/s12885-018-4613-1602941129970031]Search in Google Scholar
[50. H. Solomon, N. Dinowitz, I. S. Pateras, T. Cooks, Y. Shetzer, A. Molchadsky, M. Charni, S. Rabani, G. Koifman, O. Tarcic, Z. Porat, I. Kogan-Sakin, N. Goldfinger, M. Oren, C. C. Harris, V. G. Gorgoulis and V. Rotter, Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers, Oncogene37 (2018) 1669–1684; https://doi.org/10.1038/s41388-017-0060-810.1038/s41388-017-0060-8644859529343849]Search in Google Scholar
[51. N. C. Synnott, M. R. Bauer, S. Madden, A. Murray, R. Klinger, N. O’Donovan, D. O’Connor, W. M. Gallagher, J. Crown, A. R. Fersht and M. J. Duffy, Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007, Cancer Lett. 414 (2018) 99–106; https://doi.org/10.1016/j.canlet.2017.09.05310.1016/j.canlet.2017.09.05329069577]Search in Google Scholar
[52. H. Xiang, Y. Kinoshita, C. M. Knudson, S. J. Korsmeyer, P. A. Schwartzkroin and R. S. Morrison, Bax involvement in p53-mediated neuronal cell death, J. Neurosci. 18 (1998) 1363–1373; https://doi.org/10.1523/JNEUROSCI.18-04-01363.199810.1523/JNEUROSCI.18-04-01363.1998]Search in Google Scholar
[53. J. H. Sun, Y. J. Wen, Y. Y. Zhou, Y. M. Jiang, Y. X. Chen, H. Z. Zhang, L. H. Guan, X. P. Yao, M. Huang and H. C. Bi, p53 attenuates acetaminophen-induced hepatotoxicity by regulating drug-metabolizing enzymes and transporter expression, Cell Death Dis. 9 (2018); https://doi.org/10.1038/s41419-018-0507-z10.1038/s41419-018-0507-z594579529748533]Search in Google Scholar
[54. T. Maeda, C. Tanabe-Fujimura, Y. Fujita, C. Abe, Y. Nanakida, K. Zou, J. J. Liu, S. Y. Liu, T. Nakajima and H. Komano, NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of homocysteine-induced endoplasmic reticulum protein, Biochem. Bioph. Res. Co. 473 (2016) 1276–1280; https://doi.org/10.1016/j.bbrc.2016.04.05710.1016/j.bbrc.2016.04.057]Search in Google Scholar
[55. O. H. Rokah, O. Shpilberg and G. Granot, NAD(P)H quinone oxidoreductase protects TAp63 gamma from proteasomal degradation and regulates TAp63 gamma-dependent growth arrest, Plos One5 (2010); https://doi.org/10.1371/journal.pone.001140110.1371/journal.pone.0011401]Search in Google Scholar
[56. M. J. Lamberti, N. B. Vittar, C. da Silva Fde, V. F. Ferreira and V. A. Rivarola, Synergistic enhancement of antitumor effect of beta-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1), Phytomedicine20 (2013) 1007–1012; https://doi.org/10.1016/j.phymed.2013.04.01810.1016/j.phymed.2013.04.018]Search in Google Scholar
[57. H. Z. Zhou, H. Q. Zeng, D. Yuan, J. H. Ren, S. T. Cheng, H. B. Yu, F. Ren, Q. Wang, Y. P. Qin, A. L. Huang and J. Chen, NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma, Cell Commun. Signal17 (2019) 168; https://doi.org/10.1186/s12964-019-0491-710.1186/s12964-019-0491-7]Search in Google Scholar
[58. X. Zhang, K. Han, D.H. Yuan and C. Y. Meng, Overexpression of NAD(P)H: Quinone oxidoreductase 1 inhibits hepatocellular carcinoma cell proliferation and induced apoptosis by activating AMPK/PGC-1alpha pathway, DNA Cell Biol. 36 (2017) 256–263; https://doi.org/10.1089/dna.2016.358810.1089/dna.2016.3588]Search in Google Scholar
[59. M. Hayashi, N. Matsumoto, S. Takenoshita-Nakaya, Y. Takeba, M. Watanabe, T. Kumai, M. Takagi, M. Tanaka, T. Otsubo and S. Kobayashi, Individual metabolic capacity evaluation of cytochrome P450 2C19 by protein and activity in the small intestinal mucosa of Japanese pancreatoduodenectomy patients, Biol. Pharm. Bull. 34 (2011) 71–76; https://doi.org/10.1248/bpb.34.7110.1248/bpb.34.71]Search in Google Scholar
[60. S. Ohtsuki, O. Schaefer, H. Kawakami, T. Inoue, S. Liehner, A. Saito, N. Ishiguro, W. Kishimoto, E. Ludwig-Schwellinger, T. Ebner and T. Terasaki, Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities, Drug Metab. Dispos. 40 (2012) 83–92; https://doi.org/10.1124/dmd.111.04225910.1124/dmd.111.042259]Search in Google Scholar
[61. H. Lin and K. S. Caroll, Introduction: Posttranslational protein modification, Chem. Rev. 118 (2018) 887–888; https://doi.org/10.1021/acs.chemrev.7b0075610.1021/acs.chemrev.7b00756]Search in Google Scholar
[62. R. D. Traver, T. Horikoshi, K. D. Danenberg, T. H. W. Stadlbauer, P. V. Danenberg, D. Ross and N. W. Gibson, NAD(P)H-quinone oxidoreductase gene-expression in human colon-carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity, Cancer Res. 52 (1992) 797–802.]Search in Google Scholar
[63. X. Zhang, K. Han, D. H. Yuan and C. Y. Meng, Overexpression of NAD(P)H: quinone oxidoreductase 1 inhibits hepatocellular carcinoma cell proliferation and induced apoptosis by activating AMPK/PGC-1alpha pathway, DNA Cell Biol. 36 (2017) 256–263; https://doi.org/10.1089/dna.2016.358810.1089/dna.2016.3588]Search in Google Scholar
[64. D. Bergamaschi, M. Gasco, L. Hiller, A. Sullivan, N. Syed, G. Trigiante, I. Yulug, M. Merlano, G. Numico, A. Comino, M. Attard, O. Reelfs, B. Gusterson, A. K. Bell, V. Heath, M. Tavassoli, P. J. Farrell, P. Smith, X. Lu and T. Crook, p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis, Cancer Cell3 (2003) 387–402; https://doi.org/10.1016/s1535-6108(03)00079-510.1016/S1535-6108(03)00079-5]Search in Google Scholar